Zydus Lifesciences standalone net profit declines 46.87% in the March 2022 quarter

20 May 2022 , 02:17 PM

Net profit of Zydus Lifesciences declined 46.87% to Rs 246.90 crore in the quarter ended March 2022 as against Rs 464.70 crore during the previous quarter ended March 2021. Sales declined 1.56% to Rs 1919.20 crore in the quarter ended March 2022 as against Rs 1949.70 crore during the previous quarter ended March 2021. For the full year,net profit declined 41.88% to Rs 857.90 crore in the year ended March 2022 as against Rs 1476.20 crore during the previous year ended March 2021. Sales rose 2.06% to Rs 7590.00 crore in the year ended March 2022 as against Rs 7436.70 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	1919.20	1949.70	-2	7590.00	7436.70	2
OPM %	23.84	30.46	–	25.27	31.04	–
PBDT	469.30	556.80	-16	1961.90	2327.10	-16
PBT	346.50	441.80	-22	1483.20	1876.00	-21
NP	246.90	464.70	-47	857.90	1476.20	-42

Powered by Capital Market – Live News